JOINT CORP/THE (JYNT) Stock Price, Quote, News and Overview
NASDAQ:JYNT - Nasdaq - US47973J1025 - Common Stock - Currency: USD
JYNT Quote, Performance and Key Statistics
11.35
-0.01 (-0.09%)
The current stock price of JYNT is 11.35 USD. In the past month the price increased by 2.71%. In the past year, price increased by 15.46%.
JYNT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 14.3 | 80.15B | ||
| BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 14.59B | ||
| THC | TENET HEALTHCARE CORP | 10.89 | 12.32B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 12.12 | 11.88B | ||
| EHC | ENCOMPASS HEALTH CORP | 22.02 | 9.83B | ||
| ENSG | ENSIGN GROUP INC/THE | 22.97 | 7.26B | ||
| ACHC | ACADIA HEALTHCARE CO INC | 11.3 | 3.68B | ||
| SGRY | SURGERY PARTNERS INC | 26.93 | 3.22B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 8.6 | 2.92B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 9.02 | 2.28B | ||
| PACS | PACS GROUP INC | 16.83 | 1.98B | ||
| ARDT | ARDENT HEALTH PARTNERS INC | 36.58 | 1.98B |
Related stock screener links
About JYNT
Company Profile
The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. The company is headquartered in Scottsdale, Arizona and currently employs 444 full-time employees. The company went IPO on 2014-11-11. The firm operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment is comprised of the operating activities of the Company-owned or managed clinics. The firm operates or manages approximately 135 clinics under this segment. The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The franchise system consists of approximately 800 clinics in operation. The company offers a range of membership and wellness packages. The company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Company Info
JOINT CORP/THE
16767 N Perimeter Drive, Suite 240
Scottsdale ARIZONA 85260 US
CEO: Peter D. Holt
Employees: 619
Company Website: https://www.thejoint.com/
Investor Relations: https://ir.thejoint.com/
Phone: 14802455960
JOINT CORP/THE / JYNT FAQ
What is the stock price of JOINT CORP/THE today?
The current stock price of JYNT is 11.35 USD. The price decreased by -0.09% in the last trading session.
What is the ticker symbol for JOINT CORP/THE stock?
The exchange symbol of JOINT CORP/THE is JYNT and it is listed on the Nasdaq exchange.
On which exchange is JYNT stock listed?
JYNT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for JOINT CORP/THE stock?
11 analysts have analysed JYNT and the average price target is 16.7 USD. This implies a price increase of 47.16% is expected in the next year compared to the current price of 11.35. Check the JOINT CORP/THE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is JOINT CORP/THE worth?
JOINT CORP/THE (JYNT) has a market capitalization of 170.02M USD. This makes JYNT a Micro Cap stock.
How many employees does JOINT CORP/THE have?
JOINT CORP/THE (JYNT) currently has 619 employees.
What are the support and resistance levels for JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a support level at 10.16 and a resistance level at 11.4. Check the full technical report for a detailed analysis of JYNT support and resistance levels.
Is JOINT CORP/THE (JYNT) expected to grow?
The Revenue of JOINT CORP/THE (JYNT) is expected to grow by 2.57% in the next year. Check the estimates tab for more information on the JYNT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy JOINT CORP/THE (JYNT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of JYNT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of JYNT, evaluating the profitability, health, valuation and growth aspects
- JOINT CORP/THE (JYNT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- JOINT CORP/THE (JYNT) Sales and EPS estimates to see what analysts future expectations are.
- JOINT CORP/THE (JYNT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- JOINT CORP/THE (JYNT) Insider and Institutional Ownership to learn about the owners and their transactions.
- JOINT CORP/THE (JYNT) Stock Chart to make your own analysis
- JOINT CORP/THE (JYNT) Latest news and press-releases to stay up to date.
Does JOINT CORP/THE (JYNT) stock pay dividends?
JYNT does not pay a dividend.
When does JOINT CORP/THE (JYNT) report earnings?
JOINT CORP/THE (JYNT) will report earnings on 2025-03-13, after the market close.
What is the Price/Earnings (PE) ratio of JOINT CORP/THE (JYNT)?
JOINT CORP/THE (JYNT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.03).
What is the Short Interest ratio of JOINT CORP/THE (JYNT) stock?
The outstanding short interest for JOINT CORP/THE (JYNT) is 2.96% of its float. Check the ownership tab for more information on the JYNT short interest.
JYNT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to JYNT. When comparing the yearly performance of all stocks, JYNT turns out to be only a medium performer in the overall market: it outperformed 66.58% of all stocks.
JYNT Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to JYNT. JYNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
JYNT Financial Highlights
Over the last trailing twelve months JYNT reported a non-GAAP Earnings per Share(EPS) of -1.03. The EPS decreased by -892.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.18% | ||
| ROE | -82.42% | ||
| Debt/Equity | 0 |
JYNT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to JYNT. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 42.2% and a revenue growth 2.57% for JYNT